Peschken, Christine A <br/><br/>
Possible Consequences of a Shortage of Hydroxychloroquine for Patients with Systemic Lupus Erythematosus amid the COVID-19 Pandemic.  [electronic resource] 

 -  The Journal of rheumatology  06 2020 
 - 787-790 p.  digital 
<br/><br/> Publication Type: Editorial; Review 
<br/><br/><label>ISSN: </label>1499-2752 
<br/><br/><label>Standard No.: </label>10.3899/jrheum.200395  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Betacoronavirus<br/>COVID-19<br/>Coronavirus Infections--drug therapy<br/>Female<br/>Humans<br/>Hydroxychloroquine--supply & distribution<br/>Lupus Erythematosus, Systemic--diagnosis<br/>Male<br/>Pandemics--prevention & control<br/>Pneumonia, Viral--drug therapy<br/>Risk Assessment<br/>SARS-CoV-2<br/>United States